Paul Fields

4.4k citations

44 papers · 2.7k indexed · 1 hit paper · h-index 21

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
Genetics top 2%
- Virus-based gene therapy research

Papers in ⓘ

Transplantation 5
Oncology 20
- CAR-T cell therapy research 14
- Cancer Immunotherapy and Biomarkers 7

Co-authors: Katherine A. High (8 shared papers)Roland W. Herzog (8 shared papers)Laurie A. Boyer (4 shared papers)J. Nathan Hagstrom (5 shared papers)Linda B. Couto (5 shared papers)Valder R. Arruda (7 shared papers)Lauren E. Surface (3 shared papers)Vincent L. Butty (2 shared papers)
Journals: Blood (4 papers)Molecular Therapy (3 papers)Journal of Clinical Oncology (3 papers)Clinical Cancer Research (2 papers)Frontiers in Immunology (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Paul Fields

42 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment 2013 · 733 citations

Peers

Countries citing papers authored by Paul Fields

Since Specialization

Citations

This map shows the geographic impact of Paul Fields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Fields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Fields more than expected).

Fields of papers citing papers by Paul Fields

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Fields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Fields. The network helps show where Paul Fields may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul Fields, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Fields Line = papers co-authored together Paul Fields links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment Cell ·Carla Klattenhoff, Johanna C. Scheuermann, Lauren E. Surface, Robert K. Bradley, Paul Fields, Matthew L. Steinhauser, Huiming Ding, Vincent L. Butty, Lillian Torrey, Simon Haas, Ryan Abo, Mohammadsharif Tabebordbar, Richard Lee, Christopher B. Burge, Laurie A. Boyer Hit paper breakdown →	2013	733
2	Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector Nature Medicine ·Roland W. Herzog, Edmund Y. Yang, Linda B. Couto, J. Nathan Hagstrom, Dan Elwell, Paul Fields, Melissa Burton, Dwight A. Bellinger, Marjorie S. Read, Kenneth M. Brinkhous, Gregory M. Podsakoff, Timothy C. Nichols, Gary J. Kurtzman, Katherine A. High	1999	452
3	Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study Clinical Cancer Research ·Devalingam Mahalingam, Grey Wilkinson, Kevin H. Eng, Paul Fields, Patrick Raber, Jennifer L. Moseley, Karol Cheetham, Matt Coffey, Gerard J. Nuovo, Paweł Kaliński, Bin Zhang, Sukeshi Patel Arora, Christos Fountzilas	2019	142
4	Influence of Vector Dose on Factor IX-Specific T and B Cell Responses in Muscle-Directed Gene Therapy Human Gene Therapy ·Roland W. Herzog, Paul Fields, Valder R. Arruda, Jeff O. Brubaker, Elina Armstrong, Darryl McClintock, Dwight A. Bellinger, Linda B. Couto, Timothy C. Nichols, Katherine A. High	2002	125
5	Lack of Germline Transmission of Vector Sequences Following Systemic Administration of Recombinant AAV-2 Vector in Males Molecular Therapy ·Valder R. Arruda, Paul Fields, Ross Milner, Luanne Wainwright, María P. De Miguel, Peter Donovan, Roland W. Herzog, Timothy C. Nichols, Jaclyn A. Biegel, Mahmood K. Razavi, Mike Dake, Dale S. Huff, Alan W. Flake, Linda Couto, Mark A. Kay, Katherine A. High	2001	124
6	Role of Vector in Activation of T Cell Subsets in Immune Responses against the Secreted Transgene Product Factor IX Molecular Therapy ·Paul Fields, Dariusz Kowalczyk, Valder R. Arruda, Elina Armstrong, Mark L. McCleland, J. Nathan Hagstrom, John Pasi, Hildegund C.J. Ertl, Roland W. Herzog, Katherine A. High	2000	115
7	Risk and Prevention of Anti-factor IX Formation in AAV-Mediated Gene Transfer in the Context of a Large Deletion of F9 Molecular Therapy ·Paul Fields, Valder R. Arruda, Elina Armstrong, Kirk Chu, Federico Mingozzi, J. Nathan Hagstrom, Roland W. Herzog, Katherine A. High	2001	107
8	Posttranslational modifications of recombinant myotube-synthesized human factor IX Blood ·Valder R. Arruda, James N. Hagstrom, Jeffrey S. Deitch, Terry Heiman‐Patterson, Rodney M. Camire, Kirk Chu, Paul Fields, Roland W. Herzog, Linda B. Couto, Peter J. Larson, Katherine A. High	2001	95
9	Dynamics of genome reorganization during human cardiogenesis reveal an RBM20-dependent splicing factory Nature Communications ·Alessandro Bertero, Paul Fields, Vijay Ramani, Giancarlo Bonora, Galip Gürkan Yardımcı, Hans Reinecke, Lil Pabon, William Stafford Noble, Jay Shendure, Charles E. Murry	2019	89
10	H2A.Z: a molecular rheostat for transcriptional control F1000Prime Reports ·Vidya Subramanian, Paul Fields, Laurie A. Boyer	2015	80
11	Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter Blood ·J. Nathan Hagstrom, Linda B. Couto, Ciaran D. Scallan, Melissa Burton, Mark L. McCleland, Paul Fields, Valder R. Arruda, Roland W. Herzog, Katherine A. High	2000	67
12	AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein–specific T _H 1 response with a diverse TCR repertoire Science Translational Medicine ·Phillip A. Swanson, Marcelino Padilla, Wesley Hoyland, Kelly McGlinchey, Paul Fields, Sagida Bibi, Saul N. Faust, Adrian B. McDermott, Teresa Lambe, Andrew J. Pollard, Nicholas M. Durham, Elizabeth J. Kelly, (unknown)	2021	59
13	Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter Blood ·J. Nathan Hagstrom, Linda B. Couto, Ciaran D. Scallan, Melissa Burton, Mark L. McCleland, Paul Fields, Valder R. Arruda, Roland W. Herzog, Katherine A. High	2000	55
14	IgA-Producing Plasma Cells Originate From Germinal Centers That Are Induced by B-Cell Receptor Engagement in Humans Gastroenterology ·Francesca Barone, Anna Vossenkämper, Laurent Boursier, Wen Su, Alan M. Watson, Susan John, Deborah K. Dunn‐Walters, Paul Fields, Sonali Wijetilleka, Jonathan D. Edgeworth, Jo Spencer	2010	52
15	H2A.Z Acidic Patch Couples Chromatin Dynamics to Regulation of Gene Expression Programs during ESC Differentiation PLoS Genetics ·Vidya Subramanian, Aprotim Mazumder, Lauren E. Surface, Vincent L. Butty, Paul Fields, Allison Alwan, Lillian Torrey, Kevin K. Thai, Stuart S. Levine, Mark Bathe, Laurie A. Boyer	2013	52
16	Cronos Titin Is Expressed in Human Cardiomyocytes and Necessary for Normal Sarcomere Function Circulation ·Rebecca J. Zaunbrecher, Ashley N. Abel, Kevin M. Beussman, Andrea Leonard, Marion von Frieling-Salewsky, Paul Fields, Lil Pabon, Hans Reinecke, Xiulan Yang, Jesse Macadangdang, Deok‐Ho Kim, Wolfgang A. Linke, Nathan J. Sniadecki, Michael Regnier, Charles E. Murry	2019	49
17	Chromatin compartment dynamics in a haploinsufficient model of cardiac laminopathy The Journal of Cell Biology ·Alessandro Bertero, Paul Fields, Alec S.T. Smith, Andrea Leonard, Kevin M. Beussman, Nathan J. Sniadecki, Deok‐Ho Kim, Hung‐Fat Tse, Lil Pabon, Jay Shendure, William Stafford Noble, Charles E. Murry	2019	48
18	H2A.Z.1 Monoubiquitylation Antagonizes BRD2 to Maintain Poised Chromatin in ESCs Cell Reports ·Lauren E. Surface, Paul Fields, Vidya Subramanian, Russell Behmer, Namrata D. Udeshi, Sally E. Peach, Steven A. Carr, Jacob D. Jaffe, Laurie A. Boyer	2016	47
19	Diverse hematopoietic potentials of five human embryonic stem cell lines Experimental Cell Research ·Kai-Hsin Chang, Angelique M. Nelson, Paul Fields, Jennifer Hesson, Tatiana Ulyanova, Hua Cao, B Nakamoto, Carol B. Ware, Thalia Papayannopoulou	2008	40
20	Granulomatosis with polyangiitis involves sustained mucosal inflammation that is rich in B-cell survival factors and autoantigen Lara D. Veeken ·Yuan Zhao, Edward Odell, Lee Meng Choong, Francesca Barone, Paul Fields, Bridget S. Wilkins, Fahim M. Tungekar, Pritash Patel, Jeremy Sanderson, Shirish Sangle, David D’Cruz, Jo Spencer	2012	28

About Paul Fields

Paul Fields is a scholar working on Transplantation, Oncology, Immunology, Hematology and Genetics, having authored 44 papers that have together received 2.7k indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Virus-based gene therapy research (10 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (7 papers), Genomics and Chromatin Dynamics (6 papers), CRISPR and Genetic Engineering (6 papers), RNA Research and Splicing (5 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Cancer Research (638 citations), Genetics (1.1k citations), Molecular Biology (1.9k citations), Oncology (732 citations) and Hematology (178 citations). Paul Fields has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Katherine A. High, Roland W. Herzog, Laurie A. Boyer, J. Nathan Hagstrom, Linda B. Couto, Valder R. Arruda, Lauren E. Surface, Vincent L. Butty, Timothy C. Nichols and Matthew L. Steinhauser. Their work appears in journals such as Blood, Molecular Therapy, Journal of Clinical Oncology, Clinical Cancer Research and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact